Naloxone inhibits arrhythmias induced by coronary artery occlusion and reperfusion in anaesthetized dogs. 1986

X D Huang, and A Y Lee, and T M Wong, and C Y Zhan, and Y Y Zhao

The intravenous administration of naloxone 2 min before coronary artery occlusion in anaesthetized dogs reduced the incidence and severity of cardiac arrhythmias during coronary occlusion (20 min) and reperfusion (120 min) in a dose-related manner. It also reduced the mortality. At a dose of 1 mg kg-1 (the maximum dose used in this study) naloxone abolished the appearance of the life threatening ventricular fibrillation (VF) and ventricular tachycardia (VT) and as a consequence all dogs in this group survived. The results suggest a possible involvement of endogenous opioid peptides in arrhythmogenesis during coronary occlusion and reperfusion in the dog.

UI MeSH Term Description Entries
D008297 Male Males
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000758 Anesthesia A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

X D Huang, and A Y Lee, and T M Wong, and C Y Zhan, and Y Y Zhao
January 1994, Journal of cardiovascular pharmacology,
X D Huang, and A Y Lee, and T M Wong, and C Y Zhan, and Y Y Zhao
January 1985, Journal of cardiovascular pharmacology,
X D Huang, and A Y Lee, and T M Wong, and C Y Zhan, and Y Y Zhao
July 1957, Circulation research,
X D Huang, and A Y Lee, and T M Wong, and C Y Zhan, and Y Y Zhao
January 1980, Indian journal of physiology and pharmacology,
X D Huang, and A Y Lee, and T M Wong, and C Y Zhan, and Y Y Zhao
January 1984, Journal of molecular and cellular cardiology,
X D Huang, and A Y Lee, and T M Wong, and C Y Zhan, and Y Y Zhao
December 2013, Clinical and experimental pharmacology & physiology,
X D Huang, and A Y Lee, and T M Wong, and C Y Zhan, and Y Y Zhao
July 1984, Journal of molecular and cellular cardiology,
X D Huang, and A Y Lee, and T M Wong, and C Y Zhan, and Y Y Zhao
July 1982, European journal of pharmacology,
X D Huang, and A Y Lee, and T M Wong, and C Y Zhan, and Y Y Zhao
December 2008, British journal of pharmacology,
X D Huang, and A Y Lee, and T M Wong, and C Y Zhan, and Y Y Zhao
January 1985, British journal of pharmacology,
Copied contents to your clipboard!